ATC code H04
| ATC codes | |||
|---|---|---|---|
| H Systemic hormonal preparations, excluding sex hormones and insulins | |||
| H01 Pituitary and hypothalamic hormones and analogues | |||
| H02 Corticosteroids for systemic use | |||
| H03 Thyroid therapy | |||
| H04 Pancreatic hormones | |||
| H05 Calcium homeostasis | |||
|
| |||
ATC code H04 Pancreatic hormones is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup H04 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QH04...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H04A Glycogenolytic hormones
H04AA Glycogenolytic hormones
- H04AA01 Glucagon
References
- ↑ "ATC/DDD Index 2016: code H04". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QH04". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia - version of the Sunday, December 27, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.